Avantor (NYSE:AVTR) Stock Gets Price Target Boost from Robert W. Baird

Avantor (NYSE:AVTR) had its target price raised by equities research analysts at Robert W. Baird from $17.00 to $18.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird‘s price target points to a potential upside of 8.33% from the company’s current price.

A number of other analysts have also recently commented on the company. Jefferies Financial Group upgraded Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price objective for the company in a research report on Wednesday, July 29th. Evercore set a $17.00 price objective on shares of Avantor in a research report on Wednesday. Wells Fargo & Company upped their price objective on shares of Avantor from $14.00 to $16.00 and gave the company an “overweight” rating in a research note on Thursday, July 30th. Citigroup raised their target price on shares of Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $13.00 target price on shares of Avantor in a research note on Thursday, July 30th. Two research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $14.16.

Avantor Trading Down 3.0%

Shares of Avantor stock opened at $16.62 on Thursday. Avantor has a 1 year low of $7.26 and a 1 year high of $17.45. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.78 and a quick ratio of 1.18. The business has a 50 day moving average price of $15.40 and a 200 day moving average price of $11.20. The company has a market capitalization of $11.24 billion, a P/E ratio of -19.78, a P/E/G ratio of 9.83 and a beta of 0.94.

Avantor (NYSE:AVTR) last released its quarterly earnings results on Wednesday, October 28th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%. The company had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the firm posted $0.22 earnings per share. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. Sell-side analysts anticipate that Avantor will post 0.81 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AVTR. GSA Capital Partners LLP purchased a new position in shares of Avantor in the 2nd quarter worth about $800,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Avantor in the 2nd quarter valued at about $805,000. Assenagon Asset Management S.A. lifted its stake in shares of Avantor by 425.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company’s stock valued at $5,513,000 after purchasing an additional 450,801 shares in the last quarter. Freestone Grove Partners LP purchased a new stake in shares of Avantor during the 2nd quarter worth about $56,577,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Avantor during the 2nd quarter worth about $1,922,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Key Headlines Impacting Avantor

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Avantor reported third-quarter net sales of $1.698 billion, up 4.6% year over year, with organic growth of 5.2%. Revenue exceeded the $1.64 billion consensus estimate, while adjusted EPS of $0.22 topped expectations by $0.01. Avantor Reports Third Quarter 2026 Results
• Positive Sentiment: Both major business segments returned to growth, supporting the company’s outlook and suggesting improving demand across its life sciences and advanced technology markets. Avantor Q3 2026 Earnings: Revenue Beats Estimates as Both Segments Return to Growth
• Positive Sentiment: Management raised its full-year 2026 organic revenue-growth, adjusted EPS and free-cash-flow guidance, a potentially important catalyst for earnings estimates and investor confidence. Avantor Reports Third-Quarter and Nine-Month Results
• Neutral Sentiment: GAAP diluted EPS was $0.30, but the company remained unprofitable on a net-margin basis, which may limit the market’s reaction to the adjusted earnings beat.
• Negative Sentiment: Barclays reiterated a Sell rating and a $15 price target. That target is below the stock’s recent trading range and may reinforce concerns that the shares have moved ahead of near-term fundamentals. Barclays Keeps Sell Rating for Avantor

Avantor Company Profile

Avantor, Inc is a global provider of mission-critical products and services used in the life sciences, healthcare, education, and advanced technology industries. The company supplies chemicals, reagents, laboratory consumables, equipment, and other materials used in research, development, manufacturing, and quality-control activities.

Avantor also provides specialized solutions for biopharmaceutical production, including materials and services that support drug development, biologics manufacturing, and other bioprocessing applications.